# Richard L. Schilsky

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-l-schilsky/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,158 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 93 |
| i10-index | 320 |
| Last Known Institution | American Society of Clinical Oncology |
| OpenAlex ID | https://openalex.org/A5031299191 |
| ORCID iD | https://orcid.org/0000-0003-4474-4303 |
| Works | 558 |

## Researcher papers

- [Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741](https://scholariq.org/papers/randomized-trial-of-dose-dense-versus-conventionally-scheduled-and-sequential/)
- [Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review](https://scholariq.org/papers/circulating-tumor-dna-analysis-in-patients-with-cancer-american-society-of/)
- [American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options](https://scholariq.org/papers/american-society-of-clinical-oncology-statement-a-conceptual-framework-to-assess/)
- [Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer](https://scholariq.org/papers/effect-of-first-line-chemotherapy-combined-with-cetuximab-or-bevacizumab-on/)
- [Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)](https://scholariq.org/papers/gemcitabine-plus-bevacizumab-compared-with-gemcitabine-plus-placebo-in-patients/)
- [Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803](https://scholariq.org/papers/impact-of-physical-activity-on-cancer-recurrence-and-survival-in-patients-with/)
- [Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial](https://scholariq.org/papers/genomic-and-transcriptomic-profiling-expands-precision-cancer-medicine-the/)
- [Recommendations for management of patients with neuroendocrine liver metastases](https://scholariq.org/papers/recommendations-for-management-of-patients-with-neuroendocrine-liver-metastases/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

## Researcher university

- [American Society of Clinical Oncology](https://scholariq.org/institutions/american-society-of-clinical-oncology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.